Srishti Saha

914 total citations
30 papers, 566 citations indexed

About

Srishti Saha is a scholar working on Infectious Diseases, Epidemiology and Gastroenterology. According to data from OpenAlex, Srishti Saha has authored 30 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 16 papers in Epidemiology and 8 papers in Gastroenterology. Recurrent topics in Srishti Saha's work include Clostridium difficile and Clostridium perfringens research (20 papers), Microscopic Colitis (14 papers) and Gastrointestinal motility and disorders (8 papers). Srishti Saha is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (20 papers), Microscopic Colitis (14 papers) and Gastrointestinal motility and disorders (8 papers). Srishti Saha collaborates with scholars based in United States and India. Srishti Saha's co-authors include Sahil Khanna, Darrell S. Pardi, Raseen Tariq, Kristin C. Mara, Pritish K. Tosh, Sumitabh Singh, Sunny Singhal, Aparajit Ballav Dey, Pramod Kumar and Leslie C. Hassett and has published in prestigious journals such as Gastroenterology, Clinical Infectious Diseases and Annals of Oncology.

In The Last Decade

Srishti Saha

29 papers receiving 558 citations

Peers

Srishti Saha
Marisela Silva United States
Christopher A. Brown United States
Majdi Osman United States
Srishti Saha
Citations per year, relative to Srishti Saha Srishti Saha (= 1×) peers Julie Jarand

Countries citing papers authored by Srishti Saha

Since Specialization
Citations

This map shows the geographic impact of Srishti Saha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srishti Saha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srishti Saha more than expected).

Fields of papers citing papers by Srishti Saha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Srishti Saha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srishti Saha. The network helps show where Srishti Saha may publish in the future.

Co-authorship network of co-authors of Srishti Saha

This figure shows the co-authorship network connecting the top 25 collaborators of Srishti Saha. A scholar is included among the top collaborators of Srishti Saha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Srishti Saha. Srishti Saha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saha, Srishti & Neha U. Patel. (2023). What Should I Eat? Dietary Recommendations for Patients with Inflammatory Bowel Disease. Nutrients. 15(4). 896–896. 10 indexed citations
2.
Tariq, Raseen, William J. Tremaine, Edward V. Loftus, et al.. (2023). S244 Open Label Experience With Bismuth Subsalicylate in Patients With Microscopic Colitis. The American Journal of Gastroenterology. 118(10S). S183–S183. 1 indexed citations
3.
Saha, Srishti, et al.. (2023). Effect of peripartum Clostridioides difficile infection on pregnancy and neonatal outcomes: an observational study. Therapeutic Advances in Gastroenterology. 16. 1108353455–1108353455. 2 indexed citations
4.
Saha, Srishti, et al.. (2023). Sex-Discordant Fecal Microbiota Transplantation for Clostridioides difficile May Increase Risk of Postinfection Irritable Bowel Syndrome. Gastroenterology. 166(4). 704–706.e2. 6 indexed citations
5.
Burga, Rachel A., Kyle D. Pedro, Jacques P. Tremblay, et al.. (2021). 1008P cytoTIL15: A novel TIL therapy for melanoma with superior potency and enhanced persistence without IL2 to improve safety & efficacy and expand patient eligibility. Annals of Oncology. 32. S852–S852. 1 indexed citations
6.
Singhal, Sunny, Pramod Kumar, Sumitabh Singh, Srishti Saha, & Aparajit Ballav Dey. (2021). Clinical features and outcomes of COVID-19 in older adults: a systematic review and meta-analysis. BMC Geriatrics. 21(1). 321–321. 88 indexed citations
7.
Saha, Srishti, Kristin C. Mara, Darrell S. Pardi, & Sahil Khanna. (2021). Long-term Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection. Gastroenterology. 160(6). 1961–1969.e3. 66 indexed citations
8.
Saha, Srishti, et al.. (2021). RISK FACTORS FOR OUTCOMES OF PATIENTS WITH HISTOLOGICALLY PROVEN CHECKPOINT-INHIBITOR COLITIS. Inflammatory Bowel Diseases. 27(Supplement_1). S36–S37. 1 indexed citations
9.
Saha, Srishti, et al.. (2021). Kinetics of polymerase chain reaction positivity in patients with Clostridioides difficile infection. Therapeutic Advances in Gastroenterology. 14. 1088233419–1088233419. 1 indexed citations
10.
Tariq, Raseen, Srishti Saha, Fateeha Furqan, et al.. (2020). Prevalence and Mortality of COVID-19 Patients With Gastrointestinal Symptoms: A Systematic Review and Meta-analysis. Mayo Clinic Proceedings. 95(8). 1632–1648. 78 indexed citations
11.
Saha, Srishti, et al.. (2020). Therapies to modulate gut microbiota: Past, present and future. World Journal of Gastroenterology. 26(8). 777–788. 55 indexed citations
12.
Saha, Srishti, et al.. (2020). Preventing Opioid-Induced Constipation. JAMA Internal Medicine. 180(10). 1371–1371. 14 indexed citations
13.
Saha, Srishti, Edward V. Loftus, William J. Tremaine, et al.. (2020). Tu1793 BILE ACID MALABSORPTION AND OUTCOMES AFTER TREATMENT WITH COLESEVELAM IN MICROSCOPIC COLITIS. Gastroenterology. 158(6). S–1163. 3 indexed citations
14.
Saha, Srishti, et al.. (2020). Mo1889 CORRELATION OF EARLY INFLIXIMAB LEVELS WITH SHORT TERM OUTCOMES IN STEROID REFRACTORY ULCERATIVE COLITIS: A PILOT STUDY. Gastroenterology. 158(6). S–964. 1 indexed citations
15.
Saha, Srishti, et al.. (2020). Tu1797 MANAGEMENT OF PATIENTS WITH HISTOLOGICALLY PROVEN CHECKPOINT-INHIBITOR COLITIS. Gastroenterology. 158(6). S–1165. 1 indexed citations
16.
Saha, Srishti, Saloni Kapoor, Raseen Tariq, et al.. (2019). Increasing antibiotic resistance in Clostridioides difficile: A systematic review and meta-analysis. Anaerobe. 58. 35–46. 47 indexed citations
17.
Saha, Srishti, Raseen Tariq, Pritish K. Tosh, Darrell S. Pardi, & Sahil Khanna. (2019). Faecal microbiota transplantation for eradicating carriage of multidrug-resistant organisms: a systematic review. Clinical Microbiology and Infection. 25(8). 958–963. 73 indexed citations
18.
Saha, Srishti, et al.. (2019). 119 Kinetics of Stool Polymerase Chain Reaction in Clostridioides difficile Infection and Its Utility in Predicting Recurrence. The American Journal of Gastroenterology. 114(1). S71–S72. 1 indexed citations
19.
Saha, Srishti & Sahil Khanna. (2019). Management of Clostridioides difficile colitis: insights for the gastroenterologist. Therapeutic Advances in Gastroenterology. 12. 3973036515–3973036515. 19 indexed citations
20.
Tariq, Raseen, Abdullah Abdullah, Abdul Wahab, et al.. (2018). Outcomes of Clostridium difficile Infection in Patients With Obesity: A Nationwide Analysis. The American Journal of Gastroenterology. 113(Supplement). S121–S122. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026